HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING—
Price Investing Group
← Back to Research Watchlist
TLRY
Tilray Brands Inc
Healthcare Drug Manufacturers - Specialty & Generic · British Columbia, Canada · Reports in usd
—
Market Cap: $482.2M
Market Cap
$482.2M
Enterprise Val
$632.7M
P/E Ratio
-2.94
P/B Ratio
0.30
Trailing PEG (1Y)
0.03
As Of
Oct 8, 2026

Overview & Key Metrics

Reporting period: Aug 31, 2026 · Q1 2027
Book Value$1.61B
Gross Margin30.14%
Profit Margin30.14%
Return on Equity-10.30%
Return on Assets-7.44%
Current Ratio1.88
Debt/Equity0.23
LT Debt/Equity0.17
Revenue Per Share1.89

Income Statement

Aug 31, 2026
Revenue$257.1M
Cost of Revenue$179.6M
Gross Profit$77.5M
R&D$89.0K
SG&A$86.9M
Operating Expenses$101.6M
Operating Income-$24.1M
Interest Expense$6.5M
Tax Expense$1.7M
Net Income-$43.1M
EPS (Basic)$-0.32
EPS (Diluted)$-0.32
EBIT-$34.9M
EBITDA-$16.3M
Consolidated Income-$40.0M
Non-Controlling Interests$3.1M

Balance Sheet

Aug 31, 2026
Cash & Equivalents$218.3M
Accounts Receivable$190.6M
Inventory$329.0M
Current Assets$807.6M
LT Investments$7.1M
Property, Plant & Equipment$708.0M
Intangibles$794.8M
Non-Current Assets$1.52B
Total Assets$2.33B
Accounts Payable$335.4M
Current Debt$95.3M
Current Liabilities$430.7M
LT Debt$276.7M
Non-Current Liabilities$290.6M
Total Liabilities$721.3M
Total Debt$371.9M
Retained Earnings-$5.01B
Shareholder Equity$1.62B
Shares Outstanding136,203,579

Cash Flow Statement

Aug 31, 2026
Operating Cash Flow-$16.5M
Investing Cash Flow-$9.3M
Financing Cash Flow$14.0M
CapEx-$10.9M
Free Cash Flow-$27.4M
Depreciation & Amort.$18.6M
Stock-Based Comp$6.6M
Acquisitions / Disposals-$720.0K
Investment Activity$2.4M
Debt Issued/Repaid-$8.4M
Equity Issued/Repaid$22.3M
Dividends Paid$0.00
Net Change in Cash-$11.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h